SRINIVAS SADU's Insider Trades & SAST Disclosures
SRINIVAS SADU's most recent trade in Gland Pharma Ltd. was a Disposal of 31,562 Equity Shares done at an average price of Rs. 2700.0 . Disclosure was reported to the exchange on June 21, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for SRINIVAS SADU in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gland Pharma | SRINIVAS SADU | Director | Disposal | 21 Jun 2022 | 31,562 | 34,178 (0.02%) | 0.02% | 2700.0 | 85,218,978 | 16 Jun 2022 16 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | SRINIVAS SADU | Director | Disposal | 21 Jun 2022 | 34,178 | 0 (0%) | 0.02% | 2576.1 | 88,047,381 | 17 Jun 2022 17 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | SRINIVAS SADU | Director | Disposal | 15 Jun 2022 | 17,904 | 65,740 (0.04%) | 0.01% | 2726.6 | 48,817,785 | 13 Jun 2022 14 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | SRINIVAS SADU | Director | Disposal | 13 Jun 2022 | 78,356 | 83,644 (0.05%) | 0.05% | 2800.1 | 219,404,012 | 09 Jun 2022 10 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | SRINIVAS SADU | Director | Acquisition | 04 May 2022 | 72,000 | 162,000 (0.10%) | 0.04% | 542 | 39,024,000 | 29 Apr 2022 29 Apr 2022 |
Insider Trading | Equity Shares | ESOP |
| Gland Pharma | SRINIVAS SADU | Director | Disposal | 27 Dec 2021 | 1,958 | 90,000 (0.06%) | 0.00% | 3735.9 | 7,314,989 | 22 Dec 2021 22 Dec 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | SRINIVAS SADU | Director | Disposal | 24 Dec 2021 | 6,000 | 91,958 (0.06%) | 0.00% | 3876.9 | 23,261,280 | 23 Dec 2021 23 Dec 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | SRINIVAS SADU | Director | Disposal | 24 Dec 2021 | 10,042 | 97,958 (0.06%) | 0.01% | 3703.6 | 37,191,503 | 20 Dec 2021 21 Dec 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | SRINIVAS SADU | Director | Disposal | 15 Aug 2021 | 20,000 | 108,000 (0.07%) | 0.01% | 4262.9 | 85,258,600 | 12 Aug 2021 12 Aug 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | SRINIVAS SADU | Director | Disposal | 11 Aug 2021 | 4,685 | 128,000 (0.08%) | 0.00% | 4157.8 | 19,479,059 | 10 Aug 2021 10 Aug 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | SRINIVAS SADU | Director | Disposal | 07 Aug 2021 | 5,315 | 132,685 (0.08%) | 0.00% | 4075.5 | 21,661,096 | 05 Aug 2021 05 Aug 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | SRINIVASA SADU | Director | Disposal | 31 Jul 2021 | 30,000 | 138,000 (0.08%) | 0.02% | 4004.3 | 120,128,842 | 29 Jul 2021 30 Jul 2021 |
Insider Trading | Equity Shares | Market Sale |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.